Staphylococcus aureus colonization before infection is not associated with mortality among S. aureus-infected patients: A meta-analysis

Infection Control and Hospital Epidemiology

Volumn 33, Issue 8, 2012, Pages 796-802

  Schweizer, Marin L ^a,b   Bossen, Ann ^c   McDanel, Jennifer S ^a   Dennis, Leslie K ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA COLLEGE OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; DISEASE ASSOCIATION; HOSPITAL PATIENT; HUMAN; META ANALYSIS; MORTALITY; NURSING HOME; OUTPATIENT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

CARRIER STATE; CONFIDENCE INTERVALS; HUMANS; ODDS RATIO; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS;

EID: 84863751503     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/666628     Document Type: Article

References (28)

1. Graham PL, Lin SX, Larson EL. A U.S. population-based survey of Staphylococcus aureus colonization. Ann Intern Med 2006;144:318-325.
2. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520-532.
3. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997;10:505-520.
4. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001;344:11-16.
5. Aires de Sousa M, de Lencastre H. Bridges from hospitals to the laboratory: genetic portraits of methicillin-resistant Staph-ylococcus aureus clones. FEMS Immunol Med Microbiol 2004;40: 101-111.
6. Woeste G, Zapletal C, Wullstein C, Golling M, Bechstein WO. Influence of methicillin-resistant Staphylococcus aureus carrier status in liver transplant recipients. Transplant Proc 2005;37: 1710-1712.
7. Porter R, Subramani K, Thomas AN, Chadwick P. Nasal carriage of Staphylococcus aureus on admission to intensive care: incidence and prognostic significance. Intensive Care Med 2003;29: 655-658.
8. Campillo B, Dupeyron C, Richardet JP. Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis. Epidemiol Infect 2001;127:443-450.
9. Fortaleza CR, Melo EC, Fortaleza CM. Nasopharyngeal colonization with methicillin-resistant Staphylococcus aureus and mortality among patients in an intensive care unit. Rev Lat Am Enfermagem 2009;17:677-682.
10. Wertheim HF, Vos MC, Ott A, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004;364:703-705.
11. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955;19:251-253.
12. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
13. Petitti DB. Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis. 2nd ed. New York: Oxford University Press, 2000.
14. Lai CF, Liao CH, Pai MF, et al. Nasal carriage of methicillin-resistant Staphylococcus aureus is associated with higher all cause mortality in hemodialysis patients. Clin J Am Soc Nephrol 2011; 6:167-174.
15. Nguyen MH, Kauffman CA, Goodman RP, et al. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med 1999;130:221-225.
16. Niclaes L, Buntinx F, Banuro F, Lesaffre E, Heyrman J. Consequences of MRSA carriage in nursing home residents. Epidemiol Infect 1999;122:235-239.
17. Chang FY, Singh N, Gayowski T, Wagener MM, Marino IR. Staphylococcus aureus nasal colonization in patients with cirrhosis: prospective assessment of association with infection. Infect Control Hosp Epidemiol 1998;19:328-332.
18. Patel M, Weinheimer JD, Waites KB, Baddley JW. Active surveillance to determine the impact of methicillin-resistant Staphylococcus aureus colonization on patients in intensive care units of a Veterans Affairs medical center. Infect Control Hosp Epidemiol 2008;29:503-509.
19. Maraqa NF, Aigbivbalu L, Masnita-Iusan C, et al. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus colonization and infection among infants at a level III neonatal intensive care unit. Am J Infect Control 2011;39:35-41.
20. Konvalinka A, Errett L, Fong IW. Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery. J Hosp Infect 2006;64:162-168.
21. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebocontrolled study. Clin Infect Dis 2002;35:353-358.
22. Cimochowski GE, Harostock MD, Brown R, Bernardi M, Alonzo N, Coyle K. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg 2001;71:1572-1579.
23. Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, DAgata EM. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 2003;37:1629-1638.
24. Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010;362:9-17.
25. Nicholson MR, Huesman LA. Controlling the usage of intranasal mupirocin does impact the rate of Staphylococcus aureus deep sternal wound infections in cardiac surgery patients. Am J Infect Control 2006;34:44-48.
26. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karch-mer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36:53-59.
27. Blaine KP, Tuohy MJ, Wilson D, et al. Progression to bacteremia in critical care patients colonized with methicillin-resistant Staphylococcus aureus expressing Panton-Valentine leukocidin. Diagn Microbiol Infect Dis 2010;68:28-33.
28. Grundmeier M, Tuchscherr L, Bruck M, et al. Staphylococcal strains vary greatly in their ability to induce an inflammatory response in endothelial cells. J Infect Dis 2010;201:871-880.